Home / Peptides / NAD+ injections
NAD+ injections Dosage: What the Evidence Says (2026)
Not FDA-approved
Coenzyme sold alongside peptides. No approved injection; one small IV pharmacokinetic study.
Also called: NAD, nicotinamide adenine dinucleotide
Regulatory status (US)
There is no FDA-approved NAD+ injection. NAD and NADH are in FDA Category 1 (under evaluation), which allows pharmacy compounding under FDA's interim policy, but that is not an approval.
What it is
A coenzyme every cell uses for energy reactions. Not a peptide, but often sold and dosed alongside them.
Dosage
NAD+ injections reconstitution calculator
Enter your vial and your prescribed dose to see the units on a U-100 syringe.
What human studies show
- A 2019 pilot gave 750 mg by IV over 6 hours to healthy men to study blood levels. There are no efficacy trials for injection under the skin.
Safety
- No approved dose for any use.
Questions
- Is NAD+ injections FDA-approved?
- There is no FDA-approved NAD+ injection. NAD and NADH are in FDA Category 1 (under evaluation), which allows pharmacy compounding under FDA's interim policy, but that is not an approval.
- What dose of NAD+ injections has been studied?
- There is no established human dose. A 2019 pilot gave 750 mg by IV over 6 hours to healthy men to study blood levels. There are no efficacy trials for injection under the skin.
- How many units is my NAD+ injections dose?
- Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.
Related
The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.
BPC-15715-amino-acid peptide studied mostly in animals. Not approved; no established human dose.
TB-500 (thymosin beta-4)Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.
GHK-Cu (copper peptide)Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.
Sources
- Grant et al. 2019: Pilot pharmacokinetics of IV NAD+ in healthy men
- FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.